Thomas Althaus1,2, Yoel Lubell1,2, Venance P Maro3,4, Blandina T Mmbaga3,4,5, Bingileki Lwezaula6, Christine Halleux7, Holly M Biggs8, Renee L Galloway9, Robyn A Stoddard9, Jamie L Perniciaro10, William L Nicholson10, Kelly Doyle11, Piero Olliaro2,7, John A Crump3,4,5,8,12, Matthew P Rubach3,5,8,13. 1. Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand. 2. Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK. 3. Kilimanjaro Christian Medical Centre, Moshi, Tanzania. 4. Kilimanjaro Christian Medical University College, Moshi, Tanzania. 5. Duke Global Health Institute, Durham, NC, USA. 6. Mawenzi Regional Referral Hospital, Moshi, Tanzania. 7. Special Programme for Research and Training in Tropical Diseases, WHO, Geneva, Switzerland. 8. Division of Infectious Diseases, Department of Medicine, Duke University, Durham, NC, USA. 9. Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. 10. Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA. 11. Intermountain Central Laboratory, Intermountain Healthcare, Murray, UT, USA. 12. Centre for International Health, University of Otago, Dunedin, New Zealand. 13. Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
Abstract
OBJECTIVE: Identifying febrile patients requiring antibacterial treatment is challenging, particularly in low-resource settings. In South-East Asia, C-reactive protein (CRP) has been demonstrated to be highly sensitive and moderately specific in detecting bacterial infections and to safely reduce unnecessary antibacterial prescriptions in primary care. As evidence is scant in sub-Saharan Africa, we assessed the sensitivity of CRP in identifying serious bacterial infections in Tanzania. METHODS: Samples were obtained from inpatients and outpatients in a prospective febrile illness study at two hospitals in Moshi, Tanzania, 2011-2014. Bacterial bloodstream infections (BSI) were established by blood culture, and bacterial zoonotic infections were defined by ≥4 fold rise in antibody titre between acute and convalescent sera. The sensitivity of CRP in identifying bacterial infections was estimated using thresholds of 10, 20 and 40 mg/l. Specificity was not assessed because determining false-positive CRP results was limited by the lack of diagnostic testing to confirm non-bacterial aetiologies and because ascertaining true-negative cases was limited by the imperfect sensitivity of the diagnostic tests used to identify bacterial infections. RESULTS: Among 235 febrile outpatients and 569 febrile inpatients evaluated, 31 (3.9%) had a bacterial BSI and 61 (7.6%) had a bacterial zoonosis. Median (interquartile range) CRP values were 173 (80-315) mg/l in bacterial BSI, and 108 (31-208) mg/l in bacterial zoonoses. The sensitivity (95% confidence intervals) of CRP was 97% (83%-99%), 94% (79%-98%) and 90% (74%-97%) for identifying bacterial BSI, and 87% (76%-93%), 82% (71%-90%) and 72% (60%-82%) for bacterial zoonoses, using thresholds of 10, 20 and 40 mg/l, respectively. CONCLUSION: C-reactive protein was moderately sensitive for bacterial zoonoses and highly sensitive for identifying BSIs. Based on these results, operational studies are warranted to assess the safety and clinical utility of CRP for the management of non-malaria febrile illness at first-level health facilities in sub-Saharan Africa.
OBJECTIVE: Identifying febrile patients requiring antibacterial treatment is challenging, particularly in low-resource settings. In South-East Asia, C-reactive protein (CRP) has been demonstrated to be highly sensitive and moderately specific in detecting bacterial infections and to safely reduce unnecessary antibacterial prescriptions in primary care. As evidence is scant in sub-Saharan Africa, we assessed the sensitivity of CRP in identifying serious bacterial infections in Tanzania. METHODS: Samples were obtained from inpatients and outpatients in a prospective febrile illness study at two hospitals in Moshi, Tanzania, 2011-2014. Bacterial bloodstream infections (BSI) were established by blood culture, and bacterial zoonotic infections were defined by ≥4 fold rise in antibody titre between acute and convalescent sera. The sensitivity of CRP in identifying bacterial infections was estimated using thresholds of 10, 20 and 40 mg/l. Specificity was not assessed because determining false-positive CRP results was limited by the lack of diagnostic testing to confirm non-bacterial aetiologies and because ascertaining true-negative cases was limited by the imperfect sensitivity of the diagnostic tests used to identify bacterial infections. RESULTS: Among 235 febrile outpatients and 569 febrile inpatients evaluated, 31 (3.9%) had a bacterial BSI and 61 (7.6%) had a bacterial zoonosis. Median (interquartile range) CRP values were 173 (80-315) mg/l in bacterial BSI, and 108 (31-208) mg/l in bacterial zoonoses. The sensitivity (95% confidence intervals) of CRP was 97% (83%-99%), 94% (79%-98%) and 90% (74%-97%) for identifying bacterial BSI, and 87% (76%-93%), 82% (71%-90%) and 72% (60%-82%) for bacterial zoonoses, using thresholds of 10, 20 and 40 mg/l, respectively. CONCLUSION:C-reactive protein was moderately sensitive for bacterial zoonoses and highly sensitive for identifying BSIs. Based on these results, operational studies are warranted to assess the safety and clinical utility of CRP for the management of non-malaria febrile illness at first-level health facilities in sub-Saharan Africa.
Authors: N Díez-Padrisa; Q Bassat; L Morais; C O'Callaghan-Gordo; S Machevo; T Nhampossa; A B Ibarz-Pavón; L Quintó; P L Alonso; A Roca Journal: Trop Med Int Health Date: 2012-07-19 Impact factor: 2.622
Authors: Andrew J Bouley; Holly M Biggs; Robyn A Stoddard; Anne B Morrissey; John A Bartlett; Isaac A Afwamba; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Sarah Cleaveland; John A Crump Journal: Am J Trop Med Hyg Date: 2012-10-22 Impact factor: 2.345
Authors: Nga T T Do; Ngan T D Ta; Ninh T H Tran; Hung M Than; Bich T N Vu; Long B Hoang; H Rogier van Doorn; Dung T V Vu; Jochen W L Cals; Arjun Chandna; Yoel Lubell; Behzad Nadjm; Guy Thwaites; Marcel Wolbers; Kinh V Nguyen; Heiman F L Wertheim Journal: Lancet Glob Health Date: 2016-08-03 Impact factor: 26.763
Authors: Helena Hildenwall; Florida Muro; Jaqueline Jansson; George Mtove; Hugh Reyburn; Ben Amos Journal: Trop Med Int Health Date: 2016-12-28 Impact factor: 2.622
Authors: Heidi Hopkins; Katia J Bruxvoort; Matthew E Cairns; Clare I R Chandler; Baptiste Leurent; Evelyn K Ansah; Frank Baiden; Kimberly A Baltzell; Anders Björkman; Helen E D Burchett; Siân E Clarke; Deborah D DiLiberto; Kristina Elfving; Catherine Goodman; Kristian S Hansen; S Patrick Kachur; Sham Lal; David G Lalloo; Toby Leslie; Pascal Magnussen; Lindsay Mangham Jefferies; Andreas Mårtensson; Ismail Mayan; Anthony K Mbonye; Mwinyi I Msellem; Obinna E Onwujekwe; Seth Owusu-Agyei; Hugh Reyburn; Mark W Rowland; Delér Shakely; Lasse S Vestergaard; Jayne Webster; Virginia L Wiseman; Shunmay Yeung; David Schellenberg; Sarah G Staedke; Christopher J M Whitty Journal: BMJ Date: 2017-03-29
Authors: Laura K Erdman; Valérie D'Acremont; Kyla Hayford; Nimerta Rajwans; Mary Kilowoko; Esther Kyungu; Philipina Hongoa; Leonor Alamo; David L Streiner; Blaise Genton; Kevin C Kain Journal: PLoS One Date: 2015-09-14 Impact factor: 3.240
Authors: John A Crump; Anne B Morrissey; William L Nicholson; Robert F Massung; Robyn A Stoddard; Renee L Galloway; Eng Eong Ooi; Venance P Maro; Wilbrod Saganda; Grace D Kinabo; Charles Muiruri; John A Bartlett Journal: PLoS Negl Trop Dis Date: 2013-07-18
Authors: Yoel Lubell; Stuart D Blacksell; Susanna Dunachie; Ampai Tanganuchitcharnchai; Thomas Althaus; Wanitda Watthanaworawit; Daniel H Paris; Mayfong Mayxay; Thomas J Peto; Arjen M Dondorp; Nicholas J White; Nicholas P J Day; François Nosten; Paul N Newton; Paul Turner Journal: BMC Infect Dis Date: 2015-11-11 Impact factor: 3.090
Authors: Lukas Van Duffel; Cedric P Yansouni; Jan Jacobs; Marjan Van Esbroeck; Kadrie Ramadan; Jozefien Buyze; Achilleas Tsoumanis; Barbara Barbé; Marleen Boelaert; Kristien Verdonck; Francois Chappuis; Emmanuel Bottieau Journal: Open Forum Infect Dis Date: 2022-08-24 Impact factor: 4.423